Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2023

Shelley Wood

April 28, 2023

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

L.A. McKeown

March 14, 2023

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

News Features

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

Todd Neale

September 28, 2021

News Daily News

New Advanced Training Outlined for Future Vascular Medicine Specialists

Michael O'Riordan

January 21, 2021

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

Anticoagulation Prescription in the ED May Boost Later Use

Todd Neale

December 11, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Daily News

Hospital Readmissions at 30 Days Declining for Stroke Patients

Michael O'Riordan

August 20, 2018

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

Advertisement

October 2025 Dispatch for the CV Team

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

TCTMD’s Top 10 Most Popular Stories for April 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

New Advanced Training Outlined for Future Vascular Medicine Specialists

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Anticoagulation Prescription in the ED May Boost Later Use

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Hospital Readmissions at 30 Days Declining for Stroke Patients

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Generic ARBs Linked to Increased Adverse Events

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content